Evidence map›Paper›PMID 42421200›Full record

ArticleBioinformatics (Oxford, England)2026

RLAnOxPeptide: an integrated framework combining transformer and reinforcement learning for efficient antioxidant peptide prediction and innovative design.

Changsheng Han, Jianda Yue, Yaqi Li, Huanyu Li, Hua Tan, Zhenyu Wang, Zhihan Qi, Junbao Zhou, Zhonghua Liu, Ying Wang

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Changsheng HanThe National and Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, Hunan Normal University, Changsha, Hunan 410081, China.
Jianda YueThe National and Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, Hunan Normal University, Changsha, Hunan 410081, China.
Yaqi LiThe National and Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, Hunan Normal University, Changsha, Hunan 410081, China.
Huanyu LiThe National and Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, Hunan Normal University, Changsha, Hunan 410081, China.
Hua TanThe National and Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, Hunan Normal University, Changsha, Hunan 410081, China.
Zhenyu WangThe National and Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, Hunan Normal University, Changsha, Hunan 410081, China.
Zhihan QiThe National and Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, Hunan Normal University, Changsha, Hunan 410081, China.
Junbao ZhouThe National and Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, Hunan Normal University, Changsha, Hunan 410081, China.
Zhonghua LiuThe National and Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, Hunan Normal University, Changsha, Hunan 410081, China.
Ying WangThe National and Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, Hunan Normal University, Changsha, Hunan 410081, China.ORCID 0000-0002-4359-3753

Funding

National Natural Science Foundation of China 22473041Natural Science Foundation of Hunan Province 2024JJ2042Scientific Research Program of FuRong Laboratory 2023SK2096Scientific Research Program of XiangJiang Laboratory 25XJ03029Scientific research project of Department of Education of Hunan Province 23A0084
6 · The paper itself

Abstract

motivationBioactive peptides exhibit immense potential in pharmaceutical and food science domains, with antioxidant peptides (AOPs) garnering significant attention for their roles in scavenging free radicals. However, traditional discovery methods are inefficient and costly. This study introduces RLAnOxPeptide, an integrated computational framework that merges machine learning and reinforcement learning for the efficient prediction and de novo design of AOPs.

resultsThe framework initially establishes a high-precision predictor, RLP-T5Pred, based on the ProtT5 model via a 'protein-to-peptide' knowledge transfer strategy. By employing label smoothing and logit penalty regularization, it achieves state-of-the-art accuracy (AUC-ROC: 0.9692) and robust calibration. The second component is the generator, RLP-T5Gen, which is trained in an iterative 'Yin-Yang' loop combining supervised learning (to maintain sequence syntax) and reinforcement learning (to drive innovation). Guided by RLP-T5Pred serving as a fixed evaluator and a multi-objective reward function, the generator efficiently designs novel AOPs with high predicted activity. We experimentally validated the framework by synthesizing 17 designed peptides. Most candidates demonstrated potent radical scavenging abilities in chemical assays (DPPH and ABTS), leading to the selection of the top five candidates for cellular validation. In a t-BHP-induced HepG2 cell model, peptides Pep4, Pep5, Pep10, and Pep11 exhibited significant protective effects against oxidative damage. Consequently, the RLAnOxPeptide framework provides a powerful, experimentally verified paradigm for accelerating the discovery of novel antioxidant peptides. AVAILABILITY: The datasets generated and/or analysed during the current study, along with model outputs and representative peptide sequences, have been deposited in a public repository. The RLAnOxPeptide framework source code is available at GitHub: https://github.com/changshh/RLAnOxPeptide. An archival snapshot of the code used to perform the experiments described in this manuscript has been deposited in Zenodo with the DOI: 10.5281/zenodo.20078425. An interactive online demonstration is also available via Hugging Face Spaces: https://huggingface.co/spaces/chshan/RLAnOxPeptide.

Indexed as

AntioxidantsComputational BiologyPeptidesHumansMachine LearningPrediction AlgorithmsReinforcement Machine LearningAntioxidantsPeptides

Identifiers

PMID42421200
PMCPMC13401445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.